Digital Literacy Projects Define TDCX Foundation’s First Year
SINGAPORE–(BUSINESS WIRE)–TDCX Foundation, the social impact arm of TDCX (NYSE: TDCX), an award-winning digital customer experience (CX) solutions provider... Read more.
CatalYm Presents Data at ESMO 2023 Expanding GDF-15’s Role in Checkpoint Therapy Resistance by Inhibition of Myeloid Immune Cell Activation
– First demonstration that GDF-15 exhibits an inhibitory effect on the activation of M1 macrophages as well as direct cytotoxicity towards tumor cells –... Read more.
Novocure Announces Presence at European Society for Medical Oncology (ESMO) Congress 2023
Highlights include a new analysis showing that Tumor Treating Fields therapy, when added to standard systemic therapies, did not adversely affect patients’ quality... Read more.
Wolters Kluwer accounting industry survey reveals revenue growth remains key focus in APAC region
Survey finds that accounting firms embracing innovation, technology and cloud solutions will thrive SYDNEY–(BUSINESS WIRE)–Wolters Kluwer, a global leader... Read more.
GE HealthCare Announces Study Results Demonstrating Portrait Mobile Continuous Monitoring Solution Performance with Patients and Care Teams in the Ward
Study finds that continuous monitoring of vital signs (respiratory rate, oxygen saturation and pulse rate) with Portrait Mobile results in alarm data which may be... Read more.
PCTI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of PCTEL, Inc. Is Fair to Shareholders
NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of PCTEL, Inc. (NASDAQ: PCTI) to Amphenol Corporation... Read more.
Ray Day, APR, Vice Chair of Stagwell, Elected 2025 PRSA Chair
2024 Board of Directors Announced at Annual Leadership Assembly NASHVILLE, Tenn.–(BUSINESS WIRE)–#PRSAICON2023–PRSA today announced the newly elected... Read more.
Avistone Announces Preclinical Results for ANS014004, a Type II c-Met Tyrosine Kinase Inhibitor (TKI) at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
BEIJING, China–(BUSINESS WIRE)–Avistone Biotechnology Co., Ltd (“Avistone” or “the Company”), a clinical-stage biotechnology company focused... Read more.
Ankyra Therapeutics Presents Preliminary Phase 1 Canine Clinical Data Evaluating cANK-101 to Treat Advanced Malignant Melanoma in Dogs
First-in-class anchored IL-12 immunotherapy increases immune cell infiltration into tumors while decreasing systemic toxicity Human ANK-101, an IL-12- based anchored... Read more.
New Phase 1 Dose Escalation Cohorts Data for Aulos Bioscience’s AU-007 Show Favorable Pharmacodynamic Effects at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Interim data from an ongoing trial support overall mechanism of action of AU-007, a computationally designed human monoclonal antibody, in decreasing Tregs while... Read more.